Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Deciphera Pharmaceuticals Inc (DCPH)

Deciphera Pharmaceuticals Inc (DCPH)
25.59 +0.02 (+0.08%) 06/11/24 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
News & Headlines for Mon, Jun 10th, 2024
Tesla, Domino's Pizza rise; AMC Entertainment, SoFi Technologies fall, Monday, 4/29/2024

Stocks that traded heavily or had substantial price changes on Monday: Tesla, Domino’s Pizza rise; AMC Entertainment, SoFi Technologies fall

FULT : 16.60 (+0.97%)
DCPH : 25.59 (+0.08%)
UMBF : 96.77 (+1.50%)
DPZ : 487.97 (+0.43%)
Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment

/CNW/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international...

DCPH : 25.59 (+0.08%)
Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment

/PRNewswire/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in...

DCPH : 25.59 (+0.08%)
3 Under-the-Radar Biotech Stocks to Buy in 2023

All three biotech companies focus on oncology therapies.

MGNX : 1.7900 (+4.68%)
DCPH : 25.59 (+0.08%)
MRTX : 58.70 (-0.17%)
Why Shares of Deciphera Pharmaceuticals Rose This Week

The company's shares rose after the company reported second-quarter earnings.

DCPH : 25.59 (+0.08%)
Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 25.59 (+0.08%)
Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 25.59 (+0.08%)
Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 25.59 (+0.08%)
Deciphera Pharmaceuticals to Present at the Stifel Virtual Targeted Oncology Days

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today...

DCPH : 25.59 (+0.08%)
Why Deciphera Pharmaceuticals Stock Jumped This Week

The company's lead therapy received an FDA Breakthrough Therapy designation.

DCPH : 25.59 (+0.08%)

Barchart Exclusives

1 ‘Strong Buy’ Dividend Stock to Buy for an ‘America First’ World
GE Aerospace is emerging as a top “Strong Buy” dividend stock, with an 11% jump in revenue and a nearly $1 billion investment in U.S. manufacturing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective